Spire Health Publishes Data Showing a 65% Reduction in Hospital Admissions in Patients with COPD

14 Mar 2023
Clinical ResultExecutive Change
SAN FRANCISCO, March 14, 2023 /PRNewswire/ -- Spire Health, a leader in virtual care for chronic respiratory disease patients, has published the results of a study showing that use of their virtual care service is associated with a reduction in emergency visits and hospital admissions. The study enrolled patients with chronic obstructive pulmonary disease (COPD), the third leading cause of death worldwide. Acute exacerbations of COPD are associated with significant rates of hospitalization and accelerated disease progression.
Conducted at a multi-provider pulmonary practice, the study included 126 COPD patients who had at least one unplanned hospitalization or emergency room visit in the year prior to enrollment. Only participants enrolled in Spire for at least 12 months were enrolled. The study was approved by the Western Institutional Review Board and registered on ClinicalTrials.gov (#NCT05518981).
Published in the International Journal of COPD, this is likely the first study to investigate the clinical impact that virtual care enabled through continuous cardiorespiratory monitoring can have on healthcare resource utilization in COPD. Use of the Spire system was associated with a significant decrease in all-cause hospitalizations per patient per year (1.09 ± 0.07 to 0.38 ± 0.06, PPPMichael Polsky, a pulmonologist at Pulmonary Associates of Richmond. "Reducing acute healthcare utilization not only benefits patients but also leads to significant cost savings for healthcare providers and payers."
"Results such as these are the reason I recently joined Spire as its new CEO," said Michael J. Doyle, CEO of Spire Health. "Our clients want to live in the comfort of their homes and avoid frequent trips to the emergency room or hospital. For COPD patients, SpireSpire can help make this possible. Because at Spire, every breath counts."
Spire Health is the leading provider of virtual care for chronic respiratory disease patients in the nation. Spire's unique FDA cleared continuous virtual care system achieves extremely high levels of patient compliance which allows Spire's clinical teams greater opportunity to detect deterioration in the patient's condition and the ability to intervene in the patient's care before an admission to the hospital or trip to the emergency room. Spire is committed to providing better outcomes and quality of life for chronic respiratory patients while reducing utilization and total cost of care. Spire Health partners with leading integrated health systems, physician practices and managed care organizations across the country to help them effectively manage their cardiorespiratory patients.
Media Contact:
Nigel Smith
Next Step Communications
[email protected]
781-308-3317
SOURCE Spire Health
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Targets
-
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.